NCT06121518

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy

A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 235 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

Detailed description

This study is a Randomized, Double-blind, Multi-center, Therapeutic confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy in Essential Hypertension Patients

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	D064 and D702, QD	Experimental Group Subjects assigned to this group are treated with D064, D702
DRUG	D064 and Placebo of D702, QD	Comparator Group Subjects assigned to this group are treated with D064, placebo of D702
DRUG	Placebo of D064 and D702, QD	Comparator Group Subjects assigned to this group are treated with D702, placebo of D064

Timeline

• Start date: 2023-07-31
• Primary completion: 2024-03-22
• Completion: 2024-03-26
• First posted: 2023-11-08
• Last updated: 2024-04-05

Locations

1 site across 1 country: South Korea